Epigenetic pathogenesis of cutaneous squamous cell carcinoma

doi:10.3760/cma.j.cn371439-20200123-00080

Abstract

Abstract:

Cutaneous squamous cell carcinoma (CSCC) is a kind of malignant tumor originated from keratinocytes within the epidermis and its appendages. Its etiology and pathogenesis are complex and unclear. The incidence of CSCC is increasing in the whole world, which makes the research on its pathogenesis increasing day by day. Epigenetics does not change genome sequence, but regulates gene expression by DNA methylation, histone modification, noncoding RNA, chromatin remodeling and so on. Its reversible and stable genetic characteristics will provide a new idea for the study of pathogenesis of CSCC.

Key words: Skin neoplasms, Neoplasms, squamous cell, DNA methylation, Histone code, Non-coding RNA

Sang Yingbing, Liang Junqin. Epigenetic pathogenesis of cutaneous squamous cell carcinoma[J]. Journal of International Oncology, 2020, 47(9): 569-572.

References 22

[1]	Venables ZC, Nijsten T, Wong KF, et al. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K.2013-15: a cohort study[J]. Br J Dermatol, 2019,181(3):474-482. DOI: 10.1111/bjd.17873. doi: 10.1111/bjd.17873 pmid: 30864158
[2]	Stang A, Khil L, Kajüter H, et al. Incidence and mortality for cutaneous squamous cell carcinoma: comparison across three continents[J]. J Eur Acad Dermatol Venereol, 2019,33 Suppl 8: 6-10. DOI: 10.1111/jdv.15967. doi: 10.1111/jdv.15318 pmid: 30811690
[3]	Umezono Y, Sato Y, Noto M, et al. Incidence rate of cutaneous squamous cell carcinoma is rapidly increasing in Akita Prefecture: urgent alert for super-aged society[J]. J Dermatol, 2019,46(3):259-262. DOI: 10.1111/1346-8138.14759. doi: 10.1111/1346-8138.14759 pmid: 30614560
[4]	Hillen U, Leiter U, Haase S, et al. Advanced cutaneous squamous cell carcinoma: a retrospective analysis of patient profiles and treatment patterns—results of a non-interventional study of the DeCOG[J]. Eur J Cancer, 2018,96:34-43. DOI: 10.1016/j.ejca.2018.01.075. doi: 10.1016/j.ejca.2018.01.075 pmid: 29665511
[5]	Ando M, Saito Y, Xu G, et al. Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers[J]. Nat Commun, 2019,10(1):2415. DOI: 10.1038/s41467-019-09937-w. doi: 10.1038/s41467-019-10557-7 pmid: 31142745
[6]	Li J, Hu WX, Luo SQ, et al. Promoter methylation induced epigene-tic silencing of DAZAP2, a downstream effector of p38/MAPK pathway, in multiple myeloma cells[J]. Cell Signal, 2019,60:136-145. DOI: 10.1016/j.cellsig.2019.04.012. doi: 10.1016/j.cellsig.2019.04.012 pmid: 31034872
[7]	Hervás-Marín D, Higgins F, Sanmartín O, et al. Genome wide DNA methylation profiling identifies specific epigenetic features in high-risk cutaneous squamous cell carcinoma[J]. PLoS One, 2019,14(12):e0223341. DOI: 10.1371/journal.pone.0223341. doi: 10.1371/journal.pone.0223341 pmid: 31860637
[8]	Yang Y, Wu R, Sargsyan D, et al. UVB drives different stages of epigenome alterations during progression of skin cancer[J]. Cancer Lett, 2019,449:20-30. DOI: 10.1016/j.canlet.2019.02.010. doi: 10.1016/j.canlet.2019.02.010 pmid: 30771437
[9]	Tam S, Yao CMK, Amit M, et al. Association of immunosuppression with outcomes of patients with cutaneous squamous cell carcinoma of the head and neck[J]. JAMA Otolaryngol Head Neck Surg, 2019,146(2):128-135. DOI: 10.1001/jamaoto.2019.3751. doi: 10.1001/jamaoto.2019.3751 pmid: 31804658
[10]	Jambusaria-Pahlajani A, Crow LD, Lowenstein S, et al. Predicting skin cancer in organ transplant recipients: development of the SUNTRAC screening tool using data from a multicenter cohort study[J]. Transpl Int, 2019,12:1259-1267. DOI: 10.1111/tri.13493.
[11]	Peters FS, Peeters AMA, Mandaviya PR, et al. Differentially methy-lated regions in T cells identify kidney transplant patients at risk for de novo skin cancer[J]. Clin Epigenetics, 2018,10:81. DOI: 10.1186/s13148-018-0519-7. doi: 10.1186/s13148-018-0519-7 pmid: 29946375
[12]	Peters FS, Peeters AMA, van den Bosch TPP, et al. Disrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer[J]. Clin Exp Immunol, 2019,197(3):341-351. DOI: 10.1111/cei.13309. doi: 10.1111/cei.13309 pmid: 31059128
[13]	Gao X, Cheng Z, Yuan H, et al. K-Ras-PI3K regulates H3K56ac through PCAF to elevate the occurrence and growth of liver cancer[J]. J Cell Physiol, 2020,235(4):3905-3915. DOI: 10.1002/jcp.29284. doi: 10.1002/jcp.v235.4 pmid: 31642074
[14]	Ichise T, Yoshida N, Ichise H. CBP/p300 antagonises EGFR-Ras-Erk signalling and suppresses increased Ras-Erk signaling-induced tumour formation in mice[J]. J Pathol, 2019,249(1):39-51. DOI: 10.1002/path.5279. doi: 10.1002/path.5279 pmid: 30953353
[15]	McHugh A, Fernandes K, South AP, et al. Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivity[J]. Oncotarget, 2018,9(29):20265-20281. DOI: 10.18632/oncotarget.24750. doi: 10.18632/oncotarget.24750 pmid: 29755650
[16]	McHugh A, Fernandes K, Chinner N, et al. The identification of potential therapeutic targets for cutaneous squamous cell carcinoma[J]. J Invest Dermatol, 2020,140(6):1154-1165.e5. DOI: 10.1016/j.jid.2019.09.024. doi: 10.1016/j.jid.2019.09.024 pmid: 31705877
[17]	Xu J, Meng Q, Li X, Yang H, et al. Long noncoding RNA MIR17HG promotes colorectal cancer progression via miR-17-5p[J]. Cancer Res, 2019,79(19):4882-4895. DOI: 10.1158/0008-5472.CAN-18-3880. doi: 10.1158/0008-5472.CAN-18-3880 pmid: 31409641
[18]	Vidovic D, Huynh TT, Konda P, et al. ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells[J]. Cell Death Differ, 2020,27(1):363-378. DOI: 10.1038/s41418-019-0362-1. doi: 10.1038/s41418-019-0362-1 pmid: 31197235
[19]	He K, Li WX, Guan D, et al. Regulatory network reconstruction of five essential microRNAs for survival analysis in breast cancer by integrating miRNA and mRNA expression datasets[J]. Funct Integr Genomics, 2019,19(4):645-658. DOI: 10.1007/s10142-019-00670-7. pmid: 30859354
[20]	Gong ZH, Zhou F, Shi C, et al. miRNA-221 promotes cutaneous squamous cell carcinoma progression by targeting PTEN[J]. Cell Mol Biol Lett, 2019,24:9. DOI: 10.1186/s11658-018-0131-z. doi: 10.1186/s11658-018-0131-z pmid: 30891072
[21]	Sand M, Bechara FG, Sand D, et al. Expression profiles of long noncoding RNAs in cutaneous squamous cell carcinoma[J]. Epigenomics, 2016,8(4):501-518. DOI: 10.2217/epi-2015-0012. doi: 10.2217/epi-2015-0012 pmid: 27067026
[22]	Yu GJ, Sun Y, Zhang DW, et al. Long non-coding RNA HOTAIR functions as a competitive endogenous RNA to regulate PRAF2 expression by sponging miR-326 in cutaneous squamous cell carcinoma[J]. Cancer Cell Int, 2019,19:270. DOI: 10.1186/s12935-019-0992-x. doi: 10.1186/s12935-019-0992-x pmid: 31649487